• OphthaliX Inc., of Petach Tikva, Israel, said M. Francesca Cordeiro, professor at University College London and Imperial College in London, presented independent data showing that an A3 adenosine receptor (A3AR) agonist reduced intraocular pressure in two preclinical models of glaucoma, including partial optic nerve transection and ocular hypertension.